A future of new scientific discovery where cancer, Alzheimer's, and heart disease are considered relics of the past, and artificial intelligence agents perform a growing number of complex tasks for humans safely.

Those were among the ambitions Anthropic (ANTH.PVT) CEO Dario Amodei laid out to JPMorgan Chase (JPM) CEO Jamie Dimon Friday as the artificial intelligence startup prepares for one of the largest initial public offerings in history.

"We can have a much more beautiful world… It sounds starry-eyed. It sounds crazy. I really do believe it," Amodei said.

The remarks came during a livestreamed conversation hosted at JPMorgan's Manhattan headquarters, one of Anthropic's final stops this week in its Wall Street push to drum up investor demand for its IPO next week.

Amodei laid out a sweeping vision for the technology, from accelerating scientific discoveries and transforming medicine to deploying increasingly capable AI agents in fields such as robotics and cybersecurity.

He also pointed to the company's technology creating new markets.

"You're on an exponential of cognition, and as the exponential proceeds, new markets become possible," Amodei told Dimon.

FILE PHOTO: CEO of Anthropic Dario Amodei, addresses the gathering at the AI Impact Summit, in New Delhi, India, February 19, 2026. REUTERS/Bhawika Chhabra/File Photo · Reuters / REUTERS

But realizing those ambitions comes with enormous financial costs. Amodei described securing enough computing power to support Anthropic's growth without spending beyond its means as the company's "deepest business dilemma."

Asked by Dimon why Anthropic is going public now, the Princeton PhD pointed to the need for additional cash to help manage the uncertainty surrounding Anthropic's computing investments.

The company must commit to expensive infrastructure well before it knows how much demand its AI products will generate. Amodei said Anthropic generally purchases less capacity in advance than its growth projections might justify, supplementing it when demand exceeds expectations.

"We actually tend to buy on the low side," he said.

The IPO would provide an additional financial cushion as Anthropic balances those risks against its extraordinary growth ambitions.

"Just the more cash we have on hand, the more buffer we have between those two things," Amodei said, while suggesting the company isn't seeking to secure its highest valuation possible.

Anthropic wants to "underpromise and overdeliver," Amodei said.

Anthropic expects to price its offering Wednesday and begin trading Thursday, Nov. 19, seeking to raise as much as $90.4 billion through its IPO and a concurrent private share sale at a valuation of approximately $1.4 trillion, according to the company's IPO website.